Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 0 243 1 1 3 1,290
Aging and the Growth of Long-Term Care 1 1 1 30 1 2 5 140
An Economic Evaluation of the War on Cancer 0 0 0 96 1 1 2 357
Are the Young Becoming More Disabled? 0 0 0 93 0 0 1 345
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 0 152 0 1 1 541
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 67 0 0 0 377
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 0 1 36
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 0 0 1 35
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 0 55 0 0 11 255
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 6 0 0 3 37
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 0 6 0 0 1 53
Evaluation of Medical Technologies with Uncertain Benefits 0 0 0 48 0 0 1 43
Food Prices and the Dynamics of Body Weight 0 0 1 71 0 1 2 231
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 0 1 634
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 0 13 0 1 2 52
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 0 1 2 423
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 0 1 2 191
Insurance and Innovation in Health Care Markets 0 0 0 136 0 0 0 465
Insurance, Self-Protection, and the Economics of Terrorism 0 0 2 289 0 0 2 886
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 0 32 0 0 3 148
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 0 0 96
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 0 0 0 69
Intellectual Property and Marketing 0 0 0 0 0 0 1 1
Intellectual Property and Marketing 0 0 0 91 0 0 1 385
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 0 0 122
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 0 1 2 263
International Differences in Longevity and Health and their Economic Consequences 0 0 0 54 0 0 0 167
Mortality Risk, Insurance, and the Value of Life 0 0 0 37 0 0 2 46
Nonprofit Production 0 0 0 0 0 0 0 195
Nonprofit Production and Competition 0 0 3 299 0 2 10 1,252
Optimal Liability for Terrorism 0 0 0 40 0 0 0 211
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 0 23 0 0 3 95
Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making 0 0 14 14 0 0 8 8
The Declining Quality of Teachers 0 0 0 221 2 2 17 1,690
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 0 0 0 2 2
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 491 1 2 4 1,599
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 88 0 0 1 365
The Insurance Value of Medical Innovation 0 0 2 33 1 1 7 102
The Rise in Old Age Longevity and the Market for Long-Term Care 0 1 1 1 0 2 3 768
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 1 234 0 3 7 1,774
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 0 29 0 0 0 161
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 0 0 2 464
The Welfare Effects of Public Drug Insurance 0 0 0 77 0 1 1 285
Time-Inconsistency and Welfare 0 0 1 79 0 0 4 376
Understanding Health Disparities Across Education Groups 0 0 0 392 1 2 3 1,686
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 42 0 0 0 222
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 0 0 111
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 0 0 0 177
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 0 0 4 105
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data 0 0 0 2 0 0 1 14
Total Working Papers 1 2 27 4,230 8 25 127 19,350


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 0 0 0 56 0 0 0 213
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 0 0 0 2 0 1 2 19
A Theory of Health Disparities and Medical Technology 0 3 7 139 1 6 25 596
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) 0 0 0 2 0 1 6 19
An economic evaluation of the war on cancer 0 0 0 104 0 0 6 569
Are Biopharmaceutical Budget Caps Good Public Policy? 0 0 0 12 0 0 0 72
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 0 11 0 0 0 77
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 0 0 35 0 0 0 178
Can the ACA Improve Population Health? 0 0 0 13 0 0 0 66
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 0 1 16 0 1 3 101
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 0 26 0 2 3 105
Disability Forecasts and Future Medicare Costs 0 0 0 34 0 0 2 271
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 0 0 0 40 0 1 1 167
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 0 0 0 15
Does Medicare benefit the poor? 0 2 5 136 2 4 12 336
Economics of the Pharmaceutical Industry 0 1 19 303 0 3 38 681
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 0 0 20
Geographic Variation in Health Care: The Role of Private Markets 0 0 1 75 0 0 9 415
HIV Breakthroughs and Risky Sexual Behavior 0 0 2 166 0 0 6 909
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 0 15 0 0 0 281
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 0 0 2 96 0 0 4 304
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 0 0 1 65
Health insurance as a two-part pricing contract 0 0 0 49 0 0 1 357
Health technology assessment with risk aversion in health 0 1 2 8 0 1 9 41
Innovation and the welfare effects of public drug insurance 0 0 1 42 0 0 1 150
Insurance, self-protection, and the economics of terrorism 0 0 2 80 0 0 3 312
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 16 0 0 1 131
Labor Supply and Weight 0 2 3 47 0 4 11 133
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 3 48 0 0 4 178
Pharmaceutical advertising and Medicare Part D 0 0 0 12 0 1 1 145
Predicting quantity and quality of life with the Future Elderly Model 0 0 0 2 0 0 1 11
Prescription drug advertising and drug utilization: The role of Medicare Part D 0 0 1 1 0 4 8 8
Public Financing and the Market for Long-Term Care 0 0 0 24 0 0 1 99
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 0 14 1 1 1 92
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 1 39 0 1 5 143
Social insurance and the design of innovation incentives 0 0 0 20 0 0 0 85
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 2 71 0 0 4 292
The Economics of Teacher Quality 0 0 0 6 0 0 9 217
The Fiscal Consequences of Trends in Population Health 0 1 1 15 0 1 3 65
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation 0 0 3 3 2 5 16 16
The Labor Market Value of Health Improvements 0 0 0 44 0 0 0 151
The Rise in Old-Age Longevity and the Market for Long-Term Care 0 0 0 106 0 2 5 439
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population 0 0 0 2 0 0 1 20
The Value of Diagnostic Testing in Personalized Medicine 0 0 2 60 0 0 4 218
The economics of alternative payment models for pharmaceuticals 0 0 1 8 0 1 5 35
The growth of obesity and technological change 0 0 3 32 0 0 11 129
The insurance value of medical innovation 0 1 6 38 1 2 11 159
The nonprofit sector and industry performance 2 4 11 253 2 7 20 697
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 0 0 4 0 1 2 45
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 15 0 0 0 93
The welfare effects of medical malpractice liability 0 0 1 15 0 3 9 143
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market* 0 0 0 0 0 0 0 2
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 0 0 0 100
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 0 0 0 0 1 14
Welfare-Enhancing Technological Change and the Growth of Obesity 0 0 0 151 0 0 0 424
Total Journal Articles 2 15 80 2,540 9 53 266 10,623
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 0 0 0 23 0 0 0 105
Economics of Obesity 0 0 3 37 0 0 6 94
Economics of Obesity 0 0 0 23 2 2 5 86
Food Prices and the Dynamics of Body Weight 0 0 0 14 0 0 2 70
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 1 1 4 92 3 3 10 236
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 1 1 62
Patents, innovation, and the welfare effects of Medicare Part D 0 0 0 0 0 0 0 0
Public Financing and the Market for Long-Term Care 0 0 0 8 0 0 0 49
Total Chapters 1 1 7 209 5 6 24 702


Statistics updated 2024-05-04